| Patient | Elisabeth of Austria |
|---|---|
| Date of birth | 1837-12-24 |
| Identifiers | MRN HR-NI030-SYN-TD; SSN (made up) 000-30-5817 |
| Document date | 1894-04-28 |
| Author | Adelheid Marchetti-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Twelve-week review of anorexia nervosa, mood and sertraline. [S]
Empress Elisabeth returns eight weeks after her four-week review. She has taken sertraline 50 mg for six weeks; the nurse check two weeks after starting found only mild nausea, which passed. She has kept to the meal plan with the dietitian's help, including by video during a two-week journey, and attends CBT-E weekly. She walks about an hour a day and has not used the gymnastics apparatus. She feels warmer and steadier. Her mood is a little better; she has had no thoughts of death for three weeks. She still dislikes seeing her weight but tolerates the open weighing. [S]
| Element | Detail |
|---|---|
| Sertraline | 50 mg for six weeks; early nausea passed |
| Treatment | Weekly CBT-E; dietitian by video while travelling |
| Exercise | About an hour of walking a day |
| Safety | No thoughts of death for three weeks |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Warmer; more energy |
| Cardiovascular | Negative | No swelling, palpitations or dizziness |
| Gastrointestinal | Negative | Fullness after meals much less |
| Psychiatric | Positive | Mood a little better; PHQ-9 10 |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Thiamine 100 mg tablet, one by mouth daily for 14 days, starting before the meal plan | once daily for 14 days | Oral route | 1894-02-03 to 1894-02-17 | completed | S |
| Cholecalciferol 50 microgram (2,000 IU) capsule, one by mouth daily | once daily | Oral route | 1894-02-03 | active | S |
| Phosphorus 250 mg tablet (potassium and sodium phosphates), one by mouth twice daily with meals for three weeks | twice daily with meals | Oral route | 1894-02-10 to 1894-03-03 | completed | S |
| Calcium carbonate 1,250 mg (500 mg elemental calcium) tablet, one by mouth daily with a meal | once daily with a meal | Oral route | 1894-03-03 | active | S |
| Sertraline 25 mg tablet, one by mouth each morning for two weeks | once daily in the morning | Oral route | 1894-03-03 to 1894-03-17 | completed | S |
| Sertraline 50 mg tablet, one by mouth each morning | once daily in the morning | Oral route | 1894-03-17 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1894-04-28 | Body height | 172 | cm | S |
| 1894-04-28 | Body weight | 52 | kg | S |
| 1894-04-28 | Body mass index (BMI) [Ratio] | 17.6 | kg/m2 | S |
| 1894-04-28 | Systolic blood pressure | 104 | mm[Hg] | S |
| 1894-04-28 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1894-04-28 | Heart rate | 60 | /min | S |
| 1894-04-28 | Respiratory rate | 14 | /min | S |
| 1894-04-28 | Body temperature | 36.4 | Cel | S |
| 1894-04-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1894-04-28 | Hemoglobin [Mass/volume] in Blood | 12.4 | g/dL | 12-15.5 g/dL | Normal | S |
| 1894-04-28 | Leukocytes [#/volume] in Blood by Automated count | 4.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1894-04-28 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1894-04-28 | Potassium [Moles/volume] in Serum or Plasma | 4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1894-04-28 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 1894-04-28 | Phosphate [Mass/volume] in Serum or Plasma | 3.4 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1894-04-28 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 30 | U/L | 7-35 U/L | Normal | S |
| 1894-04-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 10 | {score} | S |
Vital signs recorded on 1894-04-28; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thin; weight 52.0 kg, BMI 17.6; temperature 36.4 C |
| Cardiovascular | Seated blood pressure 104/66, pulse 60; no orthostatic change; no edema |
| Psychiatric | Calmer; mood mildly low; no intent or plan to harm herself |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Weight loss to a body mass index of 16.0 (47.4 kg at 172 cm), about 6 kg over six months, with fatigue, swelling of both ankles, dizziness on standing, slow pulse and cold intolerance; cause not established at intake; a restrictive eating disorder suspected, with thyroid disease, celiac disease, diabetes, malignancy and adrenal insufficiency to be excluded; eating disorders psychiatry consultation requested | resolved | confirmed | R63.4 | S — Synthetic presenting problem anchored to her documented restrictive eating, low weight and swelling; superseded by the diagnosis at the consultation. |
| Anorexia nervosa, restricting type, moderate (DSM-5-TR), with compulsive exercise and frequent self-weighing, beginning in early adulthood; complicated at diagnosis by sinus bradycardia, orthostatic dizziness, ankle edema, mild anemia and leukopenia, low glucose, raised ALT and low phosphate after refeeding began | active | confirmed | F50.011 | S — Synthetic modern diagnosis made at the consultation, linked to her documented restrictive eating and exercise and to the retrospective diagnosis of anorexia nervosa (R). |
| Major depressive disorder, recurrent, moderate, with persistent grief for her son, who died five years ago; passive thoughts of death without intent or plan at intake | active | confirmed | F33.1 | S — Synthetic modern diagnosis linked to her documented mourning and ever-deepening depressions; not a claim that she was so diagnosed. |
| Low bone mass (osteopenia) of the lumbar spine and hip after decades of low weight: lumbar spine T-score -2.1, femoral neck T-score -1.8; FRAX 10-year probabilities 6.8% for a major osteoporotic fracture and 1.2% for hip fracture; no fractures | active | confirmed | M85.80 | S — Synthetic modern finding on DXA; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Weight and BMI (open weighing in the consulting room) | Weekly at first, then every visit | Completed today | 52.0 kg, BMI 17.6; up 2.4 kg in eight weeks |
| Examination | Orthostatic pulse and blood pressure, and temperature | Every visit | Completed today | Pulse 60, blood pressure 104/66, no orthostatic change; temperature 36.4 C |
| Laboratory | Sodium, potassium, phosphate, magnesium and glucose | Baseline; three to four days after nutrition starts; weekly for the first weeks; then at each visit while underweight | Completed today | Sodium 137, potassium 4.0 mmol/L, phosphate 3.4 mg/dL, magnesium 2.0 mg/dL |
| Laboratory | Blood count and liver enzymes | Baseline; repeat when abnormal | Completed today | Hemoglobin 12.4 g/dL, white cells 4.4 x10^3/uL, ALT 30 U/L: normal |
| Imaging | ECG for bradycardia and QTc | Baseline; repeat with abnormal electrolytes and before QT-prolonging drugs | Not indicated | QTc 436 ms before sertraline; pulse and electrolytes normal; no new QT-prolonging drug |
| Examination | Refeeding edema and signs of heart failure | Every visit | Completed today | No edema |
| Self-management | Exercise and compulsive activity | Every visit | Completed today | About an hour of walking a day; no gymnastics |
| Self-management | Multidisciplinary treatment: CBT-E attendance, dietitian, psychiatry | Weekly therapy; dietitian every two weeks | Completed today | Weekly CBT-E; dietitian in person and by video |
| Survey | PHQ-9 | At least monthly during acute treatment | Completed today | 10, from 16 at intake |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | No thoughts of death for three weeks; PHQ-9 item 9 scored 0. Safety plan reviewed |
| Medication safety | SSRI tolerability check two weeks after starting | 2 weeks after starting and after each dose change | Completed today | Done by nurse telephone call two weeks after starting: mild nausea only; no activation or bleeding |
| Medication safety | Adherence and adverse-effect review; sodium on an SSRI | Every visit | Completed today | No missed doses; sodium 137 mmol/L |
| Laboratory | 25-hydroxyvitamin D after repletion | About three months after starting, then yearly | Due | Due at the next review |
Goal progress:
Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023); Medical Management of Restrictive Eating Disorders in Adolescents and Young Adults (position paper) (2022); Eating Disorders: A Guide to Medical Care (AED Medical Care Standards Guide), 4th edition (2021); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders and osteoporosis monographs (2026); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)
Follow-up: Review in about nine weeks. Next scheduled visit 1894-06-30: twenty-one-week review: weight, mood, the gastroenteritis, and care while travelling. [S]